Search

everythinglearnresearchcommunity

for

Search:↓

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Intense pulsed light with radiofrequency showed mixed results in improving quality of life for hidradenitis suppurativa patients, with no clinical improvements.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Different stages and types of female hair loss are linked with age, menopause, high blood pressure, and skin conditions like acne and hirsutism.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

Topical metformin effectively treats melasma with minimal side effects.

Experts recommend specific treatments for alopecia areata based on age and severity, emphasizing the need for better treatments and acknowledging its psychological impact.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Tofacitinib is an effective and safe treatment for alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Topical flutamide works as well as hydroquinone for melasma but needs more safety checks.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.

Systemic retinoids do not increase COVID-19 risk or severity.

CGF therapy may effectively treat psoriasis by reducing inflammation.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Possible link between androgens and COVID-19 severity; more research needed.

Skin symptoms like rashes and sores can indicate COVID-19 severity, especially in older people.

Prolactin levels are higher in women with hirsutism but don't relate to its severity.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.